TYRA Stock Analysis: Buy, Sell, or Hold?
TYRA - Tyra Biosciences, Inc. Common Stock
$35.66
-1.38 (-3.73%)
▼
5d:
+4.85%
30d:
+0.28%
90d:
+22.46%
BUY
HIGH Confidence
Analysis Updated: May 18, 2026 12:00 AM ET
Earnings: May 14, 2026
0d
Smart Money Distribution
TYRA is up 7.9% this week, but smart money is buying puts. Top strike: $35 2026-07-17 with 47 OI. Put ratio: 100% View Scanner →
Strength: 9.0/10
Get Alerted When TYRA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: TYRA shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: TYRA shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: TYRA is currently trading at $35.66, which is considered fair relative to its 30-day fair value range of $34.15 to $36.58.
Technical Outlook: Technically, TYRA is in a strong uptrend. Immediate support is located at $32.26, while resistance sits at $37.27. Short-term momentum is weak, with the stock down 3.7% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $51.15 (+38.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, TYRA is in a strong uptrend. Immediate support is located at $32.26, while resistance sits at $37.27. Short-term momentum is weak, with the stock down 3.7% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $51.15 (+38.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$34.15 -
$36.58
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
75.8%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Options cheap (IV 0th percentile)
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.7%)
- BULLISH: Trading 38.1% below Wall St target ($51.15)
Trading Range Analysis
30-Day Trading Range
$34.15 -
$36.58
Current vs Trading Range
FAIR
Expected Move (7 Days)
±$4.69
(13.1%)
Support & Resistance Levels
Support Level
$32.26
Resistance Level
$37.27
Current Trend
Strong Uptrend
Technical data as of
May 18, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-13.43
Wall Street Target
$51.15
(+38.1%)
Share & Embed Analysis
Last updated: May 18, 2026 4:24 PM ET
Data refreshes hourly during market hours. Next update: 5:24 PM
Data refreshes hourly during market hours. Next update: 5:24 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TYRA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Gilla Kaplan
SELL
14295 shares
2026-03-25
Robert J More
SELL
10000 shares
2025-12-19
Robert J More
SELL
246871 shares
2025-11-21
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 52 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$126 | 55 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$28 | 52 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$103 | 53 HOLD |
